Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis
Accelerate your transition to virtual wards and dramatically reduce your elective backlogs with a single platform solution.
Huma’s expertise in building and deploying virtual wards across multiple therapeutic areas has helped NHS Trusts around the country double clinical capacity1, reduce elective backlogs, and improve patient outcomes and experience. We understand patient and clinician needs, based on over a decade of experience and learnings from more than 450 deployments.
adherence and retention rates across our care and research deployments are the result of high engagement rates 2
Our platform can almost double clinical capacity and reduce readmission rates by >30% 3
lower mortality amongst Huma patients compared with patients not using Huma 4
of patients highlighted as deteriorating had operation dates brought forward 5
Our 21 page, essential guide to Virtual Wards, brings together Huma’s 10 years of experience in implementing remote patient monitoring and virtual wards in the NHS, with practical advice on deploying technology to alleviate NHS pressures.
Contents include:
Reduction in readmission rates 6
Reduction in time spent reviewing patients 7
Reduction in time calling patients compared to traditional telemedicine 8
Reduction in outpatient appointments 9
Huma virtual wards helps increase adherence to care plans and improve outcomes through continuous remote patient monitoring and engagement at scale. With a focus on patient safety, near real-time data collection and monitoring helps clinicians optimise patient outcomes by identifying issues sooner for more timely interventions.
Huma’s award-winning, intuitive, patient-centric design encourages easier patient adoption and adherence, with 99.7% of patients reporting they found the Huma app helpful10.
.png)
Double your clinical capacity1 and cut your elective backlog in half by treating patients across multiple therapeutic areas more efficiently and effectively. Huma’s data-driven platform makes identifying and prioritising at-risk patients easier, which improves patient safety, outcomes, and experience.
Our flexible, modular design allows you to manage multiple therapeutic area waiting lists with a single platform solution and secure additional outsourced clinician resources for face-to-face, virtual, and remote care. Huma enables multiple teams and specialists to review patient data and clinician notes on a unified dashboard for improved clinician collaboration.
nhsx.nhs.uk/covid-19-response/technology-nhs/huma-medopad-evaluation-remote-digital-care-platform/
The full report is available on request. Patient feedback based on sample size of 30 responses.
Range of data from across a number of Huma projects
Hospital at Home, Heart Failure, Nurse-led, Wales
Adeline Lim, Theresa Hippchen, Inga Unger, Oliver Heinze, Andreas Welker, Hans-Georg Kräusslich, Markus A Weigand, Uta Merle, An Outpatient Management Strategy Using a Coronataxi Digital Early Warning System Reduces Coronavirus Disease 2019 Mortality, Open Forum Infectious Diseases, Volume 9, Issue 4, April 2022, ofac063, https://doi.org/10.1093/ofid/ofac063
Room 123, 13th Floor
Shanghai Tower
No. 501 Yincheng Middle Road
China
For all China enquiries
(DACH-Region)
Huma Therapeutics GmbH
Rundfunkplatz 2
80335 Munich
For all enquiries
